Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Recent Posts

2017-01-01 00:00:00

A comprehensive analysis of breast cancer microbiota and host gene expression

2017-01-01 00:00:00

Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly

2017-01-01 00:00:00

Gut microbiome alterations in Alzheimer’s disease

2017-01-01 00:00:00

Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome

2017-01-01 00:00:00

Analysis of Gut Microbiota in Patients with Parkinson’s Disease

2017-01-01 00:00:00

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients

2017-01-01 00:00:00

Gut microbiota in Parkinson disease in a northern German cohort

2017-01-01 00:00:00

Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features

2016-01-01 00:00:00

Gut microbiota in early pediatric multiple sclerosis: a case-control study

2016-01-01 00:00:00

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

← Prev 1 …42 43 44 45 46 47 Next →